• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Examining FMT for Patients With Recurrent C Difficile infections

Opinion
Video

The panelist discusses how fecal microbiota transplantation (FMT) involves transferring stool from healthy donors to restore gut microbiota in patients with recurrent Clostridioides difficile infection, though safety concerns include potential pathogen transmission and careful donor screening requirements, while OpenBiome’s standardized frozen FMT preparations have helped advance accessibility but should be used according to current FDA guidance for investigational use.

Video content above is prompted by the following:

  • Describe how FMT works and for which patients this can be used.
  • What has recent data shown about the efficacy of FMT in preventing recurrent C difficile?
  • What are the safety concerns when using FMT?
  • Discuss the recent updates of an investigational FMT therapy from OpenBiome, and how this impacts your clinical decision-making.
Related Videos
Dr Cesar Davila-Chapa
1 expert in this video
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
1 expert in this video
1 expert in this video
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.